ProMIS Neurosciences

Healthcare  |  Biotechnology
0.18 -0.0098 -5.16%
Stock Price | June 20, 2019, 3:59 p.m.
Bid: 0.16
Ask: 0.23
Prev. Close: 0.19
52 Week Low:
52 Week High:
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

ProMIS Neurosciences Inc is a Canada based biotech company. It operates in the principal business segment of research and development of aggregated misfolded proteins. The group is principally focused on the discovery and development of precision medicine therapeutics for the effective treatment of neurodegenerative diseases, in particular, Alzheimer's disease and amyotrophic lateral sclerosis. All the organization's activities are carried out in Canada. The product portfolio for the treatment of Alzheimer's disease includes PMN310, PMN350, and PMN330.

Read more Read less

Recently Viewed Tickers

Premium MicroCap Digest: The Glass Half Empty

2 years ago